Schonfeld Strategic Advisors LLC Dia Medica Therapeutics Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 16,483 shares of DMAC stock, worth $74,503. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,483
Previous 26,097
36.84%
Holding current value
$74,503
Previous $138,000
55.07%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding DMAC
# of Institutions
64Shares Held
6.11MCall Options Held
14.9KPut Options Held
1K-
Vanguard Group Inc Valley Forge, PA1.35MShares$6.11 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$2.74 Million0.01% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX600KShares$2.71 Million5.72% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA557KShares$2.52 Million0.0% of portfolio
-
Bleichroeder LP New York, NY382KShares$1.73 Million0.5% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $120M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...